Research Interest
Biography
apt. Annisa Fatharani, S.Farm, M.Sc is a pharmacist with expertise in oncology research, clinical trial design, and translational medicine. She earned her MSc in Clinical Pharmacology (Distinction) from King’s College London, where her research explored neutrophil-mediated cytotoxicity in tumor cells following mTOR inhibition. Her work involved cell culture, co-culture models, high-content imaging, and automated image analysis using Python. She also gained expertise in clinical trial methodologies and the role of clinical pharmacology in drug development.
She holds a Pharmacist Certification (apt.) from the University of Indonesia and a Bachelor of Pharmacy (S.Farm) from Andalas University. Her undergraduate research focused on HPV detection using PCR methods in cervical cancer patients, conducted in collaboration with Universiti Putra Malaysia.
With extensive experience in both research and clinical pharmacy, Annisa has worked in chemotherapy pharmacy, IV admixture, and inpatient pharmaceutical care. As a Chemotherapy and IV Admixture Pharmacist at Pondok Indah Group Private Hospital, she led the chemotherapy unit and supervised patient-centered pharmacy services. She also completed a student placement at the GSK Clinical Unit Cambridge, focusing on early-stage and first-in-human (FIH) clinical trials.
Annisa actively engages in scientific research and international collaborations, with her findings published and presented in peer-reviewed journals. Her recent research explores the integration of Artificial Intelligence (AI) in clinical research to enhance drug development and precision medicine.
Committed to advancing pharmaceutical education and translational medicine, Annisa continues contributing to life-science research and mentoring the next generation of pharmaceutical scientists.
Award
Year | Award/Grant Name | Source of Award |
2022 | LPDP Scholarship | Indonesian Endowment Fund for Education (LPDP) |
2017 | Research Funding for PKM-PE research project | Ministry of Research, Technology and Higher Education (RISTEKDIKTI), Indonesia |
2016 | Clinical Pharmacy Skill Event (CPSE) Finalist | Airlangga University, Indonesia |
Research Activity and Highlighted Project
Year | Title | Partners (if any) |
2025-present | AI Image Analysis for Cancer Cell Culture Imaging | Indonesia International Institute for Life-Sciences (i3L) |
2024-2025 | Integrating LLMs (GenAI) with Pharmacogenomics Clinical Trial Design | Dr. Ali Alsayegh, Department of Design Manufacturing and Engineering Management, University of Strathclyde, UK |
2024 | Neutrophil-Mediated Cytotoxicity Against Tumor Cells Following mTOR Inhibition | King’s College London (Sailem Group), UK |
2019-2020 | HPV Identification in Cervical Cancer Patients Using PCR Methods | Andalas University and Universiti Putra Malaysia |
2016-2017 | Chavibetle Hand Hydrogel as a Prevention for Hand-to-Hand Disease | Andalas University and RISETDIKTI |
Selected Publication
Fatharani, A., Alsayegh, A. (2025). Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models. Journal of Pharmacology and Pharmacotherapeutics, 0(0). |
Fatharani, A. (2024). Assessing Neutrophil-Mediated Cytotoxicity Against Tumor Cells Following mTOR Inhibition (Master’s dissertation). King’s College London. |
Trisnawati, A.N., Fatharani, A., Mora, F.C., Aldi, Y., Putra, A.E., Cheah, Y.K., & Marlina. (2020). Random Amplified Polymorphic DNA (RAPD) Analysis of Human papillomavirus Isolated from Cervical Cancer Patient. International Journal of Current Microbiology and Applied Sciences, 9(4), 33-42. |
Jl. Pulomas Barat Kav 88, Jakarta Timur 13210, Indonesia.
+6221 295 67 888 (Admission & Customer Service)
+6221 295 67 899 (Operator)
© 2022 Indonesia International Institute for Life Sciences. All rights reserved.